Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis - Wikidata - wikimedia - TriplyDB

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis

http://www.wikidata.org/entity/Q22241389

about

Prevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefits of stress ulcer prophylaxis What is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors?Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies Prevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative review 25 Years of Proton Pump Inhibitors: A Comprehensive Review.Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.Perils and pitfalls of long-term effects of proton pump inhibitors.A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.Cost Effectiveness of Gastroprotection with Proton Pump Inhibitors in Older Low-Dose Acetylsalicylic Acid Users in the Netherlands.Infection-related asthma.Risk of fracture and pneumonia from acid suppressive drugs.Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis.Factors associated with the initiation of proton pump inhibitors in corticosteroid users.Effects of proton pump inhibitors on lung cancer precise radiotherapy-induced radiation pneumonitis Characteristics and outcomes of patients hospitalized following pulmonary aspiration.Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: a systematic review.Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs.Proton pump inhibitors: Are we still prescribing them without valid indications?Advances in the evaluation and management of esophageal disease of systemic sclerosis.Proton pump inhibitors and the risk of pneumonia: a comparison of cohort and self-controlled case series designs Prescribing efficiency of proton pump inhibitors in China: influence and future directions Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?The impact of acid-suppressing drugs to the patients with chronic obstructive pulmonary disease: A nationwide, population-based, cohort study.Multimorbidities and Overprescription of Proton Pump Inhibitors in Older Patients Potential protective effects of Clostridium butyricum on experimental gastric ulcers in mice Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study Inhibition of Gastric Acid Secretion by H2 Receptor Antagonists Associates a Definite Risk of Enteric Peritonitis and Infectious Mortality in Patients Treated with Peritoneal Dialysis.Adverse Event Reporting for Proton Pump Inhibitor Therapy: An Overview of Systematic Reviews.Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis The Indications, Applications, and Risks of Proton Pump Inhibitors Proton Pump Inhibitors Did Not Increase Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease.eComment. The evidence for stress ulcer prophylaxis in patients undergoing cardiac surgery.Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients DUEXIS(®) (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug.

P2860

Q26768234-24C2956A-7C6A-46FA-B2E1-D7D59815CCE2 Q27025253-48FE5E96-A65C-493A-BC9E-E78AB93CF8F3 Q27026351-7A34E642-B5AF-4EE5-8855-9A5B9A710529 Q28069165-950AA936-1CB3-48E9-840E-F6FCD98F98FD Q28070003-3E95987A-B6CA-4A3D-A0BE-CC8CE386FF96 Q28072141-F04EA3CC-2853-46CA-A68A-E0F3A0503640 Q28543390-E6ED27ED-822D-483B-BDD4-3105A53CAC68 Q28595726-06691678-0D54-4FA6-BFE5-625C17478EDF Q30412203-08062579-ADED-41D9-9936-3FD187193456 Q33409626-DC115103-5A5C-462F-92A8-457A5E7B13B4 Q33441225-8DD35C9D-D011-46C4-B326-426B4ACE6DF6 Q33611577-8710C638-C02C-418A-9D84-996ACCA2669A Q33917155-77E6D205-0844-414C-B255-6073CF06E45C Q34092977-6B6B158D-418E-4B62-A173-B6A1C6C69687 Q34127482-465ADF3B-A0FB-4DAB-9D57-991F1A8760FA Q34132829-0AD172D5-562A-484A-A5F3-C3B8C90BDD74 Q34141425-85D0E4AA-3F39-4E4D-9289-A9037E05CC87 Q34277926-B18E1DB9-B945-43BD-ABD9-02F447972697 Q34299812-2BEB0D74-0911-437A-8500-575E94007E2A Q34404967-CE67EB62-2571-4935-B653-140EB7B6EB77 Q34479280-AE0CCAE9-00B3-4E63-A50D-121B42AB33F6 Q34487166-7B97E821-D7DB-46A9-947B-49919184F18C Q34636475-0BBBEFCD-ABB6-4BD5-8EFC-9620EA595B1F Q34652739-26B316CC-136E-4054-AD24-F07C05C78350 Q34666835-37D30A59-682B-4DDA-B363-9699675B8377 Q34783099-5955D355-0DBE-4060-91CF-2CE2D07679C2 Q35021173-587EF440-FA59-4E9D-BB6F-30D55C05B2F6 Q35072261-44263E3F-F789-4CD8-9340-C601987106CF Q35744820-FBCC5A8F-8C4F-40A5-957B-4E8AFBE6ECE8 Q35831677-63452DBF-0F4D-4FE9-9C9C-978EBE7F83C7 Q35865246-135A63D1-4AEE-4E6A-A78B-D55FA8888D15 Q35899886-58854364-5CF0-4C13-963E-7D54042A2FA7 Q35922573-E47E6B1C-41E6-4831-B971-9BA0B2ED67ED Q36020285-C7D63591-B8A3-4925-9247-82A91183EBD3 Q36089280-0DBB1BBD-6684-459F-887F-A893359F6ECC Q36091187-6E45334B-A951-4021-9D07-DF90584675BF Q36130637-A04DF40D-D78A-4255-9445-69EE1B579F24 Q36168618-33D4C037-C9AA-435A-8382-FF9AE96C411A Q36248841-9A482B35-2032-426C-BAA1-CB9559280C02 Q36280849-1268C92C-1894-4B0D-A2B3-628E6D0154A5

P2860

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis

http://www.wikidata.org/entity/Q22241389

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Use of acid-suppressive drugs ...... matic review and meta-analysis

@ast

Use of acid-suppressive drugs ...... matic review and meta-analysis

@en

Use of acid-suppressive drugs ...... matic review and meta-analysis

@en-gb

Use of acid-suppressive drugs ...... matic review and meta-analysis

@nl

type

label

Use of acid-suppressive drugs ...... matic review and meta-analysis

@ast

Use of acid-suppressive drugs ...... matic review and meta-analysis

@en

Use of acid-suppressive drugs ...... matic review and meta-analysis

@en-gb

Use of acid-suppressive drugs ...... matic review and meta-analysis

@nl

prefLabel

Use of acid-suppressive drugs ...... matic review and meta-analysis

@ast

Use of acid-suppressive drugs ...... matic review and meta-analysis

@en

Use of acid-suppressive drugs ...... matic review and meta-analysis

@en-gb

Use of acid-suppressive drugs ...... matic review and meta-analysis

@nl

P1433

Q22241389-A3517421-B7AB-45A5-AD8C-FFFD922595D8

P1476

Q22241389-D3C32693-3114-48F0-B3CC-12940DFFAC42

P2093

Q22241389-31CD8A7E-8529-42E8-AB09-3F129E155855

Q22241389-442B707F-5B2C-401A-BBA9-66702E5BA4FD

Q22241389-5797385B-8007-4541-8F36-97DE0D8B1306

Q22241389-AB5D0578-17A8-483A-8BE3-F28F0A5FA1F2

Q22241389-DE75F4F4-F882-46AE-8F10-172B745E40B9

Q22241389-E7F3A1FB-47A1-49ED-BBAF-2AD78A651340

P2860

Q22241389-00570398-2770-41FF-B59A-E216CEDB1FFD

Q22241389-00DFB0BB-17E8-4C01-853C-81A0A94029F7

Q22241389-082BBE5E-132C-4E5C-BF7F-5E48C56B34AF

Q22241389-0E53DE3B-3502-48B4-82AD-39B9FC62243C

Q22241389-19627312-1761-46B8-9639-DBA10CC38048

Q22241389-1C53BE3A-A6A2-4A94-A006-9F843D05186E

Q22241389-1E4EF24D-24D2-401C-B9C5-E8AC68EE7169

Q22241389-1FA57F49-EE1A-4E2B-9999-CA1EAB2E9C14

Q22241389-1FFFD4CF-6D56-4741-9B7A-4CA6503D24B6

Q22241389-2501B0D3-1565-457E-BBDE-D68B71203249

P304

Q22241389-0486CE5A-3DAB-4670-95B4-C55E4A0C3F42

P31

Q22241389-0A79F531-FECA-4F6F-A791-C52D189E8C93

Q22241389-68AC3E45-1FA7-4FA9-9346-0CCFB93970C7

Q22241389-ACBD84B0-A64F-49B0-9797-F169B09BA55A

P3181

Q22241389-A56FDFD7-3A92-418D-8D5B-97227E564378

P356

Q22241389-6E14DECA-613E-4778-A7C3-305787BF987E

P407

Q22241389-69FD4716-0601-4150-ABFD-781B74BCB1D6

P433

Q22241389-77A90FB6-618E-4657-A228-F65088186965

P478

Q22241389-5EF29FB1-A2B6-48AC-A324-CD4E27D5806D

P577

Q22241389-FB4CB8E8-5F0F-4DD1-A39F-B3FF910A8792

P5875

Q22241389-A8CA84B5-1C7C-4418-B811-590A50FFDE67

P698

Q22241389-A17EBDBC-03C6-4C2B-8BC6-1C3532587622

P921

Q22241389-24358D0B-7EBE-47BB-AD69-3BA72FF0AD45

Q22241389-7A7E7BBB-070A-407C-9EEC-007D4BDE120C

P932

Q22241389-2C019D63-FD60-4E44-B706-2FF3D6A91B4C

P3181

P356

P1433

Canadian Medical Association Journal

P1476

Use of acid-suppressive drugs ...... matic review and meta-analysis

@en

P2093

Christie Y Jeon

http://www.w3.org/2001/XMLSchema#string

Chun-Sick Eom

http://www.w3.org/2001/XMLSchema#string

Eun-Geol Cho

http://www.w3.org/2001/XMLSchema#string

Ju-Won Lim

http://www.w3.org/2001/XMLSchema#string

Kang-Sook Lee

http://www.w3.org/2001/XMLSchema#string

Sang Min Park

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Measuring inconsistency in meta-analyses

Meta-analysis in clinical trials

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

Overuse of acid-suppressive therapy in hospitalized patients.

Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.

Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.

Acid-suppressive medication use and the risk for hospital-acquired pneumonia.

P304

310-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

1535349

http://www.w3.org/2001/XMLSchema#string

P356

10.1503/CMAJ.092129

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

183

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49697534

http://www.w3.org/2001/XMLSchema#string

P698

21173070

http://www.w3.org/2001/XMLSchema#string

P921

P932

3042441

http://www.w3.org/2001/XMLSchema#string